tldrdaily.news logo
Tag

Acinetobacterbaumannii

All articles tagged with #acinetobacterbaumannii

health1 year ago

Antibiotic-Resistant Super-Strain Spreads Rapidly Across Asia

A new study has identified a highly antibiotic-resistant strain of Acinetobacter baumannii (ST164) spreading in Asian ICUs, posing a global health risk. This strain, found to have twice the resistance levels of previous strains, underscores the urgent need for rigorous infection control and monitoring in hospitals. The research highlights the critical role of genomic surveillance in tracking the spread of this drug-resistant bacteria, which poses severe challenges to patient outcomes and healthcare systems worldwide.

via SciTechDaily|
#acinetobacterbaumannii#antibioticresistance#genomicsurveillance
health-and-medicine2 years ago

"Zosurabalpin: A New Antibiotic Breakthrough Battles Drug-Resistant Superbugs"

Swiss scientists have discovered a new antibiotic, zosurabalpin, which is effective against drug-resistant gram-negative bacteria, specifically targeting Acinetobacter baumannii. This breakthrough, the first in over 50 years, could combat the growing issue of antimicrobial resistance, which is responsible for millions of deaths annually. Zosurabalpin operates by blocking the bacteria's ability to form a protective outer membrane, leading to its death. Currently in phase 1 clinical trials, this discovery opens the door to potentially treating a range of drug-resistant infections and is a significant step forward in the fight against the "silent pandemic" of antibiotic resistance.

via New York Post |
##acinetobacterbaumannii#antibioticresistance
health-and-medicine2 years ago

"Breakthrough Antibiotic Zosurabalpin Targets Drug-Resistant Superbugs"

Swiss scientists have discovered a new antibiotic, zosurabalpin, which is effective against drug-resistant gram-negative bacteria, particularly Acinetobacter baumannii. This antibiotic works by blocking the lipopolysaccharide (LPS) responsible for the bacteria's protective outer membrane, causing the bacteria to die. Zosurabalpin represents the first new class of antibiotic against these bacteria in over 50 years and is currently undergoing phase 1 clinical trials. The breakthrough is significant as antimicrobial resistance is projected to cause more deaths than cancer in the next 30 years, and this discovery could lead to the development of more drugs to combat resistant bacteria.

via Fox News|
##acinetobacterbaumannii#antibioticresistance
health-and-medicine2 years ago

"Breakthrough Antibiotic Offers Hope Against Drug-Resistant Superbugs"

Researchers at Harvard University and Roche have developed an experimental antibiotic named zosurabalpin that effectively kills the drug-resistant superbug Acinetobacter baumannii. This breakthrough represents a new class of drugs, as it targets Gram-negative bacteria, which are notoriously difficult to treat due to their complex membrane structures and resistance strategies. Zosurabalpin, which is already in clinical trials, works by clogging a transport system in the bacteria, leading to lethal toxicity. This discovery is significant as it offers hope against infections with mortality rates of 40 to 60 percent and could lead to more treatments for drug-resistant infections.

via Ars Technica|
##acinetobacterbaumannii#antibioticresistance
health-and-medicine2 years ago

"Breakthrough Antibiotic Emerges to Combat Superbugs with Unprecedented Resistance-Fighting Method"

Researchers have developed a new antibiotic called Zosurabalpin, which shows promise in treating drug-resistant Acinetobacter baumannii, a deadly bacteria responsible for serious infections and high mortality rates. This novel antibiotic, which is now in phase 1 clinical trials, operates by disrupting the bacteria's outer membrane, a method that could potentially be applied to other resistant Gram-negative bacteria. The breakthrough comes after a 50-year gap since the last class of antibiotics was approved to combat such pathogens, offering hope in the global fight against antimicrobial resistance.

via CNN|
##acinetobacterbaumannii#antibioticresistance